Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Sort descending Drug Company PI Date Risk List Available?
Raltegravir (Isentress) Merck July 2020 YES
Ribavirin Aurobindo Pharma Limited October 2018
Rifabutin Greenstone LLC April 2018
Rifabutin (Mycobutin) Pfizer April 2018
Rifampicin Macleods Pharmaceuticals Limited December 2018
Rifampin Lannett Company Inc. September 2019
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Rifapentine (Priftin) Sanofi-Aventis June 2020 YES
Rilpivirine (Edurant) Janssen May 2019 YES
Ritonavir (Norvir) Tablets/Oral Solution AbbVie December 2019
Semaglutide (Ozempic) Novo Nordisk April 2019
Tamoxifen Citrate Mylan Pharmaceuticals April 2013
Tenofovir Disoproxil Fumarate (Viread) Gilead Sciences April 2019 YES
Trimethoprim/Sulfamethoxazole (Septra) Pfizer August 2018
VinCRIStine Sulfate Hospira, Inc. October 2019
Vorinostat (Zolinza) Merck January 2020
Zidovudine (Retrovir) Capsules, Syrup and IV Injection GlaxoSmithKline September 2018 YES